0.00Open8.70Pre Close0 Volume0 Open Interest88.00Strike Price0.00Turnover474.85%IV-2.03%PremiumDec 13, 2024Expiry Date10.28Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.8593Delta0.0268Gamma7.55Leverage Ratio-4.9759Theta-0.0004Rho-6.48Eff Leverage0.0039Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet